Elite Pharmaceuticals (ELTP) Net Income (2010 - 2026)
Elite Pharmaceuticals' Net Income came in at $5.91 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$5.88 million a year earlier and down 68.0% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Net Income (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Elite Pharmaceuticals reported Net Income of $56.67 million; for FY2026 (ended Mar 31, 2026), it was $44.87 million.
- Net Income carries a five-year compound annual growth rate of 61.0% (FY2021 to FY2026).
- Going back by fiscal year, Net Income was -$4.4 million in FY2025, $20.15 million in FY2024 (+465.6%), $3.56 million in FY2023 (-55.7%) and $8.04 million in FY2022 (+94.0%).
- The five-year range for quarterly Net Income is -$11.04 million (fiscal Q2 2025) to $18.59 million (fiscal Q3 2026).
- The fastest year-over-year change in Net Income over five years came in fiscal Q2 2024 (growth of 885.7%), and the weakest in fiscal Q1 2023 (a decline of 80.1%).
- Business Quant data shows ELTP's Net Income at $18.46 million (Q4 2026), $18.59 million (Q3 2026) and $13.7 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 5.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.91 Mn |
| Mar 31, 2026 | 18.46 Mn |
| Dec 31, 2025 | 18.59 Mn |
| Sep 30, 2025 | 13.70 Mn |
| Jun 30, 2025 | -5.88 Mn |
| Mar 31, 2025 | 17.00 Mn |
| Dec 31, 2024 | -10.89 Mn |
| Sep 30, 2024 | -11.04 Mn |
| Jun 30, 2024 | 615,773.00 |
| Mar 31, 2024 | 3.33 Mn |
| Dec 31, 2023 | 706,354.00 |
| Sep 30, 2023 | 14.93 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | -1.23 Mn |
| Dec 31, 2022 | 2.97 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 305,883.00 |
| Mar 31, 2022 | 2.43 Mn |
| Dec 31, 2021 | 2.28 Mn |
| Sep 30, 2021 | 1.80 Mn |
API Access
Elite Pharmaceuticals Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();